NCT05053022View on ClinicalTrials.gov

A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 29, 2021

Primary Completion Date

November 21, 2022

Study Completion Date

January 24, 2023

Conditions
Vitiligo
Interventions
DEVICE

Skinpen Precision System

Subjects will receive a total of 8-12 treatments with the Skinpen Precision system targeting their Vitiligo lesions.

Trial Locations (1)

75234

Crown Laboratories, Dallas

Sponsors
All Listed Sponsors
lead

Crown Laboratories, Inc.

INDUSTRY

NCT05053022 - A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo | Biotech Hunter | Biotech Hunter